CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation

Department of Microbiology and Oncology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan
Biochimica et Biophysica Acta (Impact Factor: 4.66). 03/2013; 1833(6). DOI: 10.1016/j.bbamcr.2013.03.006
Source: PubMed


Human T-cell leukemia virus type 1 (HTLV-1) infection is associated with the development of adult T-cell leukemia (ATL) and various inflammatory diseases. CD69 is a marker of early activation of lymphocytes. We investigated the effects of HTLV-1 infection on the expression of CD69. The CD69 gene was upregulated in all viral protein Tax-expressing HTLV-1-transformed T-cell lines, except MT-2 and peripheral blood mononuclear cells (PBMCs) from patients with ATL compared with uninfected T-cell line, Tax-negative ATL-derived T-cell lines and normal PBMCs. Flow cytometric analysis and immunohistochemical analysis confirmed the enhanced expression of CD69 in HTLV-1-transformed T-cell lines and in ATL cells in lymph nodes and skin lesions, and its absence in MT-2 and PBMCs. CD69 expression was induced following infection of human T-cell line with HTLV-1, and specifically by Tax. Tax transcriptionally activated CD69 gene through both nuclear factor-κB (NF-κB) and cyclic adenosine 3',5'-monophosphate response element-binding protein signaling pathways. Detailed analysis of the CD69 promoter indicated that the Tax-induced expression of CD69 was regulated by multiple cis-acting elements and by the interplay of transcription factors of the NF-κB, early growth response and cyclic adenosine 3',5'-monophosphate response element-binding protein families. The lack of CD69 expression in MT-2 is due to epigenetic mechanism involving deacetylation, but not methylation. We conclude that CD69 is a Tax-regulated gene, and its regulation by Tax may play a role in cellular activation and HTLV-1-induced disease pathogenesis.

Download full-text


Available from: Masachika Senba, Jul 01, 2015
1 Follower
15 Reads
  • Source
    • "Kim et al. (2008) provided evidence that Tax-1 induces Bcl-3 expression primarily through activation of the NF-κB pathway. Another recent study has demonstrated that Tax-1 transactivates CD69, a marker of early activation of lymphocytes, through both NF-κB and CREB signaling pathways (Ishikawa et al., 2013). Tax-1-mediated activation of the non-canonical NF-κB pathway is important in virus-induced tumorigenesis. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Human T cell leukemia viruses (HTLVs) are complex human retroviruses of the Deltaretrovirus genus. Four types have been identified thus far, with HTLV-1 and HTLV-2 much more prevalent than HTLV-3 or HTLV-4. HTLV-1 and HTLV-2 possess strictly related genomic structures, but differ significantly in pathogenicity, as HTLV-1 is the causative agent of adult T cell leukemia and of HTLV-associated myelopathy/tropical spastic paraparesis, whereas HTLV-2 is not associated with neoplasia. HTLVs code for a protein named Tax that is responsible for enhancing viral expression and drives cell transformation. Much effort has been invested to dissect the impact of Tax on signal transduction pathways and to identify functional differences between the HTLV Tax proteins that may explain the distinct oncogenic potential of HTLV-1 and HTLV-2. This review summarizes our current knowledge of Tax-1 and Tax-2 with emphasis on their structure, role in activation of the NF-κB (nuclear factor kappa-B) pathway, and interactions with host factors.
    Frontiers in Microbiology 09/2013; 4:271. DOI:10.3389/fmicb.2013.00271 · 3.99 Impact Factor
  • Source
    • "The early activation antigen CD69 is a type I1 integral membrane glycoprotein included in the natural killer cell gene complex family of signal transducing receptors [44–46]. CD69 represents one of the earliest activation markers of T lymphocytes appearing within 1–2 h after stimulation [47, 48]. Consequently, CD69 expression has been used as a marker of T cell activation both in vivo and in vitro [49–51]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this research was to assess plasma magnesium (Mg) concentration, the frequencies of activated T CD4+ and T CD8+ lymphocytes and B lymphocytes in adolescents with hyperthyroidism due to Graves' disease (GD), and to assess changes in the above-mentioned parameters during methimazole (MMI) treatment. The frequencies of activated T and B cells were measured by flow cytometry method and plasma Mg concentration was determined by spectrophotometry method in 60 adolescents at the time of GD diagnosis and after receiving the normalisation of the thyroid hormones levels. The control group consisted of 20 healthy volunteers. We observed lower plasma Mg concentration, and higher frequencies of activated T and B lymphocytes in the study group before the treatment in comparison with healthy controls, and with study group in MMI-induced euthyreosis (p < 0.01).Statistically significant negative correlations between the percentages of activated T CD3+, T CD4+, T CD8+ and B CD19+ lymphocytes, and plasma Mg concentration before the treatment were found (r < -0.335, p < 0.002). After the treatment no vital differences in plasma Mg concentration, and in percentages of activated cells between GD patients and controls were found, except CD8+CD25+ cells (p = 0.03). The present study demonstrates that both activated T and B cells might play an important role in the pathogenesis of GD, and activation is related to Mg plasma level. The use of MMI in treatment of hyperthyroidism due to GD leads to decrease the frequencies of activated lymphocytes and normalisation of Mg levels.
    Biological trace element research 05/2013; DOI:10.1007/s12011-013-9690-z · 1.75 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pathoepigenetics is a new discipline describing how disturbances in epigenetic regulation alter the epigenotype and gene expression pattern of human, animal or plant cells. Such 'epigenetic reprogramming' may play an important role in the initiation and progression of a wide variety of diseases. Infectious diseases also belong to this category: recent data demonstrated that microbial pathogens, including bacteria and viruses, are capable of dysregulating the epigenetic machinery of their host cell. The resulting heritable changes in host cell gene expression may favor colonization, growth or the spread of infectious pathogens. It may also facilitate the establishment of latency and malignant cell transformation. In this article, we review how bacterial epigenetic effectors and inflammatory processes elicited by bacteria alter the host cell epigenotype, and describe how oncoproteins encoded by human tumor viruses act as epigenetic dysregulators to alter the phenotype and behaviour of host cells.
    Future Virology 12/2013; 8(11):1-16. DOI:10.2217/fvl.13.97 · 1.01 Impact Factor
Show more

Similar Publications